Table of Contents
International Journal of Family Medicine
Volume 2014, Article ID 103853, 7 pages
Research Article

Prescription Practice for Diabetes Management among a Female Population in Primary Health Care

1Medical College, AL Imam Mohammed Islamic University, Riyadh, Saudi Arabia
2King Fahad Cardiac Center, King Khalid Hospital, Medical College, King Saud University, P.O. Box 93254 Riyadh, Saudi Arabia

Received 17 November 2013; Accepted 13 February 2014; Published 20 March 2014

Academic Editor: Christos D. Lionis

Copyright © 2014 Fouzia A. ALHreashy and Abdulelah F. Mobierek. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Introduction. Prescription for diabetes care is an important practice in primary care. Methods. This is a descriptive study carried out on at primary care clinics over a five-month period at Al Imam Medical Complex, Riyadh, Saudi Arabia. It was cross-sectional study of 160 female diabetic patients, who visited the services between January and May, 2012. Data were collected from the medical records on the clinical characteristics and drugs prescribed for their diabetic management. Results. The majority of the sample population (82%) was older than 40 years old. Half of them had concomitant hypertension, hyperlipidemia, and obesity. There were 500 prescriptions for diabetes management. More than 57% of participants were on two or more drugs for hyperglycemia. Metformin was the most common drug prescribed. Metformin and sulphonylurea were the most common combined medications. Most of cases ( 70%) were on a combination of antihypertensive drugs. ACE or ARBs and diuretic was the most common combined prescriptions. Statins and aspirin were used by 41% and 23.8% of the research population, respectively. Conclusion. Polypharmacy is a feature in diabetes care. Most of the prescription practice for diabetic care follows the recommended guidelines for hyperglycemia and hypertension. Management of dyslipidemia among diabetic patients, however, is an area that needs to be developed.